Grit Biotherapeutics

Grit Biotherapeutics is dedicated to the research, development, and application of tumor-infiltrating lymphocytes (TILs). As a high-tech innovative enterprise, it focuses on cutting-edge global biotechnology and specializes in the field of immunotherapy for solid tumors. Its core competitiveness stems from its highly professional and experienced founding team, composed of overseas-educated Ph.D. holders, as well as an academician-level scientific advisory board. The company has also established strategic partnerships with multiple top-tier hospitals in China.